Lysophosphatidylcholine pretreatment reduces VLA-4 and P-selectin-mediated B16.F10 melanoma cell adhesion in vitro and inhibits metastasis-like lung invasion in vivo

Molecular Cancer Therapeutics

Volumn 10, Issue 1, 2011, Pages 186-197

  Jantscheff, Peter ^a   Schlesinger, Martin ^b   Fritzsche, Juliane ^b   Taylor, Lenka A ^a   Graeser, Ralph ^c   Kirfel, Gregor ^b   Fürst, Dieter O ^b   Massing, Ulrich ^a   Bendas, Gerd ^b  

^a TUMOR BIOLOGY CENTER   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c PROQINASE GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; HEPARIN; LYSOPHOSPHATIDYLCHOLINE; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; DRUG EFFECT; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID COMPOSITION; LUNG METASTASIS; MALE; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN BINDING; THROMBOCYTE ACTIVATION;

ANIMALS; CELL ADHESION; CELL MEMBRANE; HUMANS; INTEGRIN ALPHA4BETA1; LUNG NEOPLASMS; LYSOPHOSPHATIDYLCHOLINES; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; P-SELECTIN; RECOMBINANT PROTEINS;

EID: 78751536306     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-10-0474     Document Type: Article

References (51)

1. Vantyghem SA, Wilson SM, Postenka CO, Al-Katib W, Tuck AB, Chambers AF. Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res 2005;65:3396-403. (Pubitemid 40524625)
2. Fokas E, Engenhart-Cabillic R, Daniilidis K, Rose F, An HX. Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev 2007;26:705-15.
3. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239-52.
4. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009;9:302-12.
5. Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008;8:618-31.
6. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009;9:274-84.
7. Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009;9:285-93.
8. Graeser R, Bornmann C, Esser N, Ziroli V, Jantscheff P, Unger C, et al. Antimetastatic effects of liposomal gemcitabine and empty liposomes in an orthotopic mouse model of pancreatic cancer. Pancreas 2009;38:330-7.
9. Mead JF, Alfin-Slater RB, Howton DR, Popjak G. Lipids: chemistry, biochemistry and Nutrition. New York: Plenum Press; 1986.
10. Phillips GB, Dodge JT. Composition of phospholipids and of phospholipid fatty acids of human plasma. J Lipid Res 1967;8:676-81.
11. Antar MA, Ohlson MA, Osborn MO. Fatty acid composition of different serum phospholipids in men and women. Biochem J 1967;105:117-9.
12. Kashiwagi M, Friess H, Uhl W, Berberat P, Abou-Shady M, Martignoni M, et al. Group II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis. Gut 1999;45:605-12.
13. Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res 1968;9:155-67.
14. Chen S, Subbaiah PV. Phospholipid and fatty acid specificity of endothelial lipase: potential role of the enzyme in the delivery of docosahexaenoic acid (DHA) to tissues. Biochim Biophys Acta 2007;1771:1319-28. (Pubitemid 47499233)
15. Aoki J, Inoue A, Makide K, Saiki N, Arai H. Structure and function of extracellular phospholipase A1 belonging to the pancreatic lipase gene family. Biochimie 2007;89:197-204.
16. Raffelt K, Moka D, Sullentrop F, Dietlein M, Hahn J, Schicha H. Systemic alterations in phospholipid concentrations of blood plasma in patients with thyroid carcinoma: an in-vitro (31)P high-resolution NMR study. NMR Biomed 2000;13:8-13.
17. Kuliszkiewicz-Janus M, Tuz MA, Baczynski S. Application of 31P MRS to the analysis of phospholipid changes in plasma of patients with acute leukemia. Biochim Biophys Acta 2005;1737:11-5.
18. 31P NMR spectroscopy of blood plasma: determination and quantification of phospholipid classes in patients with renal cell carcinoma. NMR Biomed 2002;15:60-8.
19. Kriat M, Vion-Dury J, Confort-Gouny S, Favre R, Viout P, Sciaky M, et al. Analysis of plasma lipids by NMR spectroscopy: application to modifications induced by malignant tumors. J Lipid Res 1993; 34:1009-19.
20. 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers. Anticancer Res 1996;16:1587-94.
21. Taylor LA, Arends J, Hodina AK, Unger C, Massing U. Plasma lysophosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status. Lipids Health Dis 2007;6:17.
22. Bornmann C, Graeser R, Esser N, Ziroli V, Jantscheff P, Keck T, et al. A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging. Cancer Chemother Pharmacol 2008;61:395-405.
23. Jantscheff P, Esser N, Graeser R, Ziroli V, Kluth J, Unger C, et al. Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts. Prostate 2009;69:1151-63.
24. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 1995;55:3752-6.
25. Snyder F, Snyder C. Glycerolipids and cancer. Prog Biochem Pharmacol 1975;10:1-41.
26. Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim Biophys Acta 2002;1582:81-8. (Pubitemid 34634114)
27. Meyer zu Heringdorf D, Jakobs KH. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta 2007;1768:923-40.
28. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol 2007;7:964-74.
29. Scott GA, Arioka M, Jacobs SE. Lysophosphatidylcholine mediates melanocyte dendricity through PKCzeta activation. J Invest Dermatol 2007;127:668-75.
30. Bartolome RA, Wright N, Molina-Ortiz I, Sanchez-Luque FJ, Teixido J. Activated G(alpha)13 impairs cell invasiveness through p190Rho-GAP-mediated inhibition of RhoA activity. Cancer Res 2008;68: 8221-30.
31. Qiao J, Huang F, Naikawadi RP, Kim KS, Said T, Lum H. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4. Am J Physiol Lung Cell Mol Physiol 2006;291:L91-101.
32. Ludwig RJ, Boehme B, Podda M, Henschler R, Jager E, Tandi C, et al. Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res 2004;64:2743-50.
33. Laubli H, Stevenson JL, Varki A, Varki NM, Borsig L. L-Selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest. Cancer Res 2006;66:1536-42.
34. Fritzsche J, Simonis D, Bendas G. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches. Thromb Haemost 2008;100:1166-75.
35. Niers TM, Bruggemann LW, Klerk CP, Muller FJ, Buckle T, Reitsma PH, et al. Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung. Clin Exp Metastasis 2009;26:171-8.
36. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-7.
37. Hinz B, Alt W, Johnen C, Herzog V, Kaiser HW. Quantifying lamella dynamics of cultured cells by SACED, a new computer-assisted motion analysis. Exp Cell Res 1999;251:234-43.
38. Svitkina TM, Shevelev AA, Bershadsky AD, Gelfand VI. Cytoskeleton of mouse embryo fibroblasts. Electron microscopy of platinum replicas. Eur J Cell Biol 1984;34:64-74.
39. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000;6:100-2. (Pubitemid 30048535)
40. Dimitroff CJ, Lechpammer M, Long-Woodward D, Kutok JL. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 2004;64:5261-9.
41. Glinsky VV, Glinsky GV, Glinskii OV, Huxley VH, Turk JR, Mossine VV, et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res 2003;63:3805-11.
42. Thomas SN, Zhu F, Schnaar RL, Alves CS, Konstantopoulos K. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem 2008;283:15647-55.
43. Honn KV, Tang DG, Crissman JD. Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev 1992;11:325-51.
44. Karpatkin S, Pearlstein E. Role of platelets in tumor cell metastases. Ann Intern Med 1981;95:636-41.
45. Sin WC, Zhang Y, Zhong W, Adhikarakunnathu S, Powers S, Hoey T, et al. G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers. Oncogene 2004;23: 6299-303.
46. Machesky LM. Lamellipodia and filopodia in metastasis and invasion. FEBS Lett 2008;582:2102-11.
47. Mansilla MC, Banchio CE, de Mendoza D. Signalling pathways controlling fatty acid desaturation. Subcell Biochem 2008;49:71-99.
48. Stulnig TM, Huber J, Leitinger N, Imre EM, Angelisova P, Nowotny P, et al. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J Biol Chem 2001;276:37335-40.
49. Callaghan R, Stafford A, Epand RM. Increased accumulation of drugs in a multidrug resistant cell line by alteration of membrane biophysical properties. Biochim Biophys Acta 1993;1175:277-82.
50. Hac-Wydro K, Wydro P. The influence of fatty acids on model cholesterol/phospholipid membranes. Chem Phys Lipids 2007; 150:66-81.
51. Alexander M, Schlesinger M, Jantscheff P, Massing U, Bendas G. Reduction in human melanoma cell adhesion receptor activity by lysophosphatidylcholine (LPC) treatment - functional characterization and signal pathway analyses. Int J Clin Pharmacol Ther 2010;48: 478-80.